Sat, 18 Apr 2026

November 23, 2022

people moves

Hong Kong-based Immuno Cure BioTech names new CFO

FutureCFO Editors November 23, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies,

Recent posts

APAC to drive agentic future of commerce

Proven strategies for breaking ceilings and building legacies

EY unveils enterprise-scale agentic AI for audit

Aspire teams up with J. P. Morgan Payments to boost FX efficiency

Philippine CFOs call for AI governance, data readiness and an end to pilot traps

Indonesian capital market sees foreign fund outflow boost

Subscribe